Mallinckrodt Pharmaceuticals
Investor Lawsuit Targets Mallinckrodt for Alleged False Statements Regarding Financial Health
SG Tylor
After Mallinckrodt Pharmaceuticals’ emergence from Chapter 11 reorganization and a $1.7 billion settlement for opioid claims, the company now faces ...
